JOSE ANTONIO FRANCHINI RAMIRES

(Fonte: Lattes)
Índice h a partir de 2011
22
Projetos de Pesquisa
Unidades Organizacionais
Departamento de Cardio-Pneumologia, Faculdade de Medicina - Docente
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 10 de 24
  • conferenceObject
    Impact of chronic kidney disease on diabetic patients with stable coronary disease undergoing surgery, angioplasty or medical treatment in a ten-year follow-up
    (2018) BATISTA, D. V.; HUEB, W.; LINHARES FILHO, J. P. P.; SILVA, R. R.; LIMA, E. G.; REZENDE, P. C.; MARTINS, E. B.; GARZILLO, C. L.; AZEVEDO, D. F. C.; RAMIRES, J. A. F.; KALIL FILHO, R.
  • conferenceObject
    SYNTAX score and outcomes after coronary artery bypass grafting: a long-term follow-up analysis
    (2018) MARTINS, E. B.; HUEB, W.; SILVA, R. R.; LINHARES FILHO, J. P. P.; BATISTA, D. V.; RIBAS, F. F.; REZENDE, P. C.; LIMA, E. G.; AZEVEDO, D. F. C.; RAMIRES, J. A. F.; KALIL FILHO, R.
  • article 4 Citação(ões) na Scopus
    Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial
    (2018) HUEB, Thiago; ROCHA, Mauricio S.; SIQUEIRA, Sergio F.; NISHIOKA, Silvana Angelina D'Orio; PEIXOTO, Giselle L.; SACCAB, Marcos M.; LIMA, Eduardo Gomes; GARCIA, Rosa Maria Rahmi; RAMIRES, Jos Antonio F.; KALIL FILHO, Roberto; MARTINELLI FILHO, Martino
    Background: Patients with ischemic cardiomyopathy and severe left ventricular dysfunction have a worse survival prognosis than patients with preserved ventricular function. The role of diabetes in the long-term prognosis of this patient group is unknown. This study investigated whether the presence of diabetes has a long-term impact on left ventricular function. Methods: Patients with coronary artery disease who underwent coronary artery bypass graft surgery, percutaneous coronary intervention, or medical therapy alone were included. All patients had multivessel disease and left ventricular ejection fraction measurements. Overall mortality, nonfatal myocardial infarction, stroke, and additional interventions were investigated. Results: From January 2009 to January 2010, 918 consecutive patients were selected and followed until May 2015. They were separated into 4 groups: G1, 266 patients with diabetes and ventricular dysfunction; G2, 213 patients with diabetes without ventricular dysfunction; G3, 213 patients without diabetes and ventricular dysfunction; and G4, 226 patients without diabetes but with ventricular dysfunction. Groups 1, 2, 3, and 4, respectively, had a mortality rate of 21.6, 6.1, 4.2, and 10.6% (P < .001); nonfatal myocardial infarction of 5.3, .5, 7.0, and 2.6% (P < .001); stroke of .40, .45, .90, and .90% (P = NS); and additional intervention of 3.8, 11.7, 10.3, and 2.6% (P < .001). Conclusion: In this sample, regardless of the treatment previously received patients with or without diabetes and preserved ventricular function experienced similar outcomes. However, patients with ventricular dysfunction had a worse prognosis compared with those with normal ventricular function; patients with diabetes had greater mortality than patients without diabetes.
  • conferenceObject
    Abnormal Release of Cardiac Biomarkers in the Presence of Myocardial Edema Evaluated by Cardiac Magnetic Resonance After Uncomplicated Revascularization Procedures
    (2018) RIBAS, Fernando F.; REZENDE, Paulo C.; BOROS, Gustavo A.; DALLAZEN, Anderson R.; LINHARES FILHO, Jaime P.; NOMURA, Cesar H.; ROCHITTE, Carlos E.; VILLA, Alexandre V.; LIMA, Eduardo G.; CARVALHO, Guilherme F.; HUEB, Whady; RAMIRES, Jose A.; KALIL FILHO, Roberto
  • bookPart
    Prefácio do volume
    (2018) RAMIRES, José Antonio Franchini
  • conferenceObject
    Cost-effectiveness analysis of on-pump and off-pump coronary artery bypass grafting for patients with multivesselcoronary artery disease: a Markov model based on data from the MASS III trial
    (2018) SCUDELER, T. L.; HUEB, W.; SOAREZ, P. C. De; CAMPOLINA, A. G.; HUEB, A. C.; REZENDE, P. C.; LIMA, E. G.; GARZILLO, C. L.; RIBAS, F. F.; TAKIUTI, M. E.; RAMIRES, J. A. F.; KALIL FILHO, R.
  • conferenceObject
    Predictors of returning to work in the long-run after an acute coronary syndrome episode
    (2018) NICOLAU, J. C.; LARA, L.; DALCOQUIO, T.; BARACIOLI, L. M.; FURTADO, R. H. M.; FRANCI, A.; COSTA, M. S. S.; FERRARI, A. G.; SCANAVINI FILHO, M. A.; GODOY, L. C.; RAMIRES, J. A. F.; KALIL-FILHO, R.; SILVA, J. C.
  • bookPart
    Medicações utilizadas no tratamento de arritmias na emergência
    (2018) NEVES, Carolina Frezzatti de Andrade; OLIVETTI, Natália Quintella Sangiorgi; PAULA, Leonardo Jorge Cordeiro de; RAMIRES, José Antônio Franchini
  • conferenceObject
    Impact of glycated hemoglobin in diabetic patients with coronary artery disease undergoing surgery, angioplasty or clinical treatment in a very long-term follow-up
    (2018) LINHARES FILHO, J. P. P.; HUEB, W.; BATISTA, D. V.; SILVA, R. R.; LIMA, E. G.; REZENDE, P. C.; MARTINS, E. B.; GARZILLO, C. L.; AZEVEDO, D. F. C.; RAMIRES, J. A. F.; KALIL FILHO, R.
  • article 8 Citação(ões) na Scopus
    Predictors of death in chronic Chagas cardiomyopathy patients with pacemaker
    (2018) PEIXOTO, Giselle de Lima; MARTINELLI FILHO, Martino; SIQUEIRA, Sergio Freitas de; NISHIOKA, Silvana Angelina D'Orio; PEDROSA, Anisio Alexandre Andrade; TEIXEIRA, Ricardo Alkmim; COSTA, Roberto; KALIL FILHO, Roberto; RAMIRES, Jose Antonio Franchini
    Background: Chronic Chagas cardiomyopathy (CCC) is the most serious and frequent manifestation of Chagas disease. Conduction abnormalities and bradycardia requiring pacemaker are common. The aim of this study was to determine the rate and predictors of death in CCC patients with pacemaker. Methods: In this single-center prospective cohort study we assessed the outcome of 396 CCC patients with pacemaker, followed-up for at least 24 months. All patients underwent a clinical and device assessment, 12-lead electrocardiography and echocardiography. Results: During the median follow-up of 1.9 years (Interquartile range 1.6-2.4), there were 65 (16.4%) deaths, yielding an annual mortality rate of 8.6%. The major cause was sudden death (33.8%), followed by heart failure (HF), 32.3%. All the investigated variables were examined as potential predictors of death. The final multivariate logistic regression model included five independent variables: advanced HF functional class (OR [odds ratio] 6.71; 95% confidence interval [95% CI] 1.95-23.2; P = 0.003), renal disease (OR 5.71; 95% CI 1.80-18.0; P = 0.003), QRS >= 150 ms (OR 2.80; 95% CI 1.08-7.27; P = 0.034), left atrial enlargement (OR 2.75; 95% CI 1.09-6.95; P = 0.032) and left ventricular ejection fraction = 43% (OR 2.31; 95% CI 1.07-4.97; P = 0.032). Themodel had good discrimination, confirmed by bootstrap validation (optimism-adjusted c-statistic of 0.78) and the calibration curve showed a proper calibration (slope = 0.972). Conclusions: CCC patients with pacemaker have a high annual mortality rate despite that the pacemaker related variables were not predictors of death. The independent predictors of death can help us to identify the poor prognosis patients.